EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism


, : Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. Journal of Rheumatology 26(3): 540-545

Objective. Palindromic rheumatism is characterized by attacks of acute arthritis of short duration. In the long term, a substantial proportion of patients will develop rheumatoid arthritis (RA) or other connective tissue diseases, but the determinants of subsequent chronic disease have not been adequately established. We identify clinical prognostic factors for the development of RA and other connective tissue diseases in patients with palindromic rheumatism in a retrospective cohort study. Methods. The medical records of 4900 patients with arthritis referred from 1986 to 1996 to 3 rheumatologists at an academic center were reviewed. One hundred sixty patients were diagnosed as having palindromic rheumatism. After review, 127 complied with diagnostic criteria for palindromic rheumatism. Disease duration was estimated as time of first attack until the last consultation, or the development of RA or other connective tissue disease. Survival analysis including Cox regression was used to identify clinical variables associated with the risk of developing RA or other connective tissue disease, adjusting for varying disease duration. Results. Sixty-five percent of the patients were female. Age at onset was 40 +- 12 years. Mean disease duration was 6 +- 6 years, and mean followup by the rheumatologists was 40 +- 45 months. Joints more frequently affected were wrist, knee, and metacarpophalangeal. Forty-three patients (34%) subsequently developed a connective tissue disease including 36 (28%) RA, 3 (2%) systemic lupus erythematosus, and 4 (3%) other connective tissue diseases. In the final Cox regression model the hazard ratio for development of a connective tissue disease in the presence of a positive rheumatoid factor (RF) was 2.9 (p = 0.002), for proximal interphalangeal (PIP) joint involvement 2.4 (p = 0.02), for wrist involvement 2.5 (p = 0.05), for female sex 2.2 (p = 0.05), and for age at onset 1.03 (per year) (p = 0.001). Female patients with positive RF and involvement of the hands had an 8-fold risk of developing disease, compared with patients with one or fewer of these features. Conclusion. Positive RF and early involvement of the wrist and PIP joints predict the subsequent development of RA or other connective tissue disease in patients with palindromic rheumatism, and identify a group of patients at increased risk.


Accession: 011206164

PMID: 10090159

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Gonzalez-Lopez, L.; Gamez-Nava, J.I.; Jhangri, G.; Russell, A.S.; Suarez-Almazor, M.E., 2000: Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. A retrospective cohort study based on a review of medical records was conducted to evaluate the outcome of patients with palindromic rheumatism referred to an academic centre in Alberta, Canada, from 1986 to 1996; 113 patients complied with the se...

Gonzalez Lopez, L.; Gamez Nava, J.I.; Jhangri, G.S.; Ramos Remus, C.; Russell, A.S.; Suarez Almazor, M.E., 1997: Prognostic factors for the development of a secondary connective tissue disease in patients with palindromic rheumatism. Arthritis & Rheumatism 40(9 SUPPL ): S150, Sept

Powell, A.; Davis, P.; Jones, N.; Russell, A.S., 2008: Palindromic rheumatism is a common disease: comparison of new-onset palindromic rheumatism compared to new-onset rheumatoid arthritis in a 2-year cohort of patients. Objective. To determine the prevalence of palindromic rheumatism (PR) compared to new-onset rheumatoid arthritis (RA).Methods. We reviewed. 145 patients that had been newly diagnosed by a rheumatologist with either RA or PR between May 2004 and M...

Alarcon, G., S.; Willkens, R., F.; Ward, J., R.; Clegg, D., O.; Morgan, J., G.; Ma, K.-Ni; Singer, J., Z.; Steen, V., D.; Paulus, H., E.; Luggen, M., E.; Polisson, R., P.; Ziminski, C., M.; Yarboro, C.; Williams, H.J.mes, 1996: Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: Followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Objective. To examine the musculoskeletal manifestations in a large cohort of patients (n = 410) diagnosed with either a well-established connective tissue disease (CTD) (n = 197) or an early undifferentiated CTD (n = 213) with a symptom duration...

Alarcón, G.S.; Willkens, R.F.; Ward, J.R.; Clegg, D.O.; Morgan, J.G.; Ma, K.N.; Singer, J.Z.; Steen, V.D.; Paulus, H.E.; Luggen, M.E.; Polisson, R.P.; Ziminski, C.M.; Yarboro, C.; Williams, H.J., 1996: Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. To examine the musculoskeletal manifestations in a large cohort of patients (n = 410) diagnosed with either a well-established connective tissue disease (CTD) (n = 197) or an early undifferentiated CTD (n = 213) with a symptom duration of <1 ye...

Tamai, M.; Kawakami, A.; Iwamoto, N.; Arima, K.; Aoyagi, K.; Eguchi, K., 2010: Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. To determine which variables at baseline are predictive for the development of rheumatoid arthritis (RA) from palindromic rheumatism (PR) in a Japanese population. Anti-cyclic citrullinated peptide (anti-CCP) antibodies, joint involvement pattern,...

Anonymous, 1960: Evaluation of pituitary-adrenocortical function in patients with rheumatoid arthritis following steroid therapy In Connective tissue and diseases of connective tissue

Fisher, L.R.; Kirk, A.; Awad, J.; Festenstein, H.; Alonso, A.; Perry, J.D.; Shipley, M., 1986: HLA antigens in palindromic rheumatism and palindromic onset rheumatoid arthritis. Fifty patients who presented with typical palindromic rheumatism of at least 6 months' duration were tissue-typed for HLA A, B, C antigens. DR typing was also performed but was not possible for technical reasons in three patients. Twenty-thre...

Shingu, M.; Obata, K.; Ezaki, I.; Tomari, K.; Fujikawa, Y.; Wada, T.; Nonaka, S.; Suenaga, Y.; Iwata, K.; Nobunaga, M., 1995: Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis. Stromelysin-1 (MMP-3) is a metalloproteinase that degrades articular cartilage matrix in patients with rheumatoid arthritis (RA). We measured MMP-3 in the sera from patients with RA and other connective tissue diseases using specific sandwich EIA...

Procaccia, S.; Gasparini, A.; Colucci, A.; Lanzanova, D.; Bianchi, M.; Forcellini, P.; Villa, P.; Blasio, R.; Zanussi, C., 1987: ELISA determined IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis and in other connective tissue diseases. We used an adaptation of an enzyme-linked immunoadsorbent assay (ELISA) to determine serum levels of IgM, IgG and IgA rheumatoid factors (RF) in 50 patients with classic or definite rheumatoid arthritis (RA) according to the ARA criteria, balanced...